I'd Double a Position in These 3 Dividend Stocks Right Now Without Any Hesitation

Source Motley_fool

Key Points

  • AbbVie's shift towards immunology treatments points to continued dividend growth for this pharmaceutical stock.

  • Chevron's efforts at financial discipline could pay off in terms of dividend growth and stock price appreciation.

  • PepsiCo may be out of favor, but investors can scoop up shares at a discounted price and higher dividend yield.

  • 10 stocks we like better than AbbVie ›

With the stock market trading sideways since the start of summer, concerns are running high about a possible near-term downturn. Rather than exiting the market, consider leaning into defensive names.

Blue chip dividend stocks are a prime example. These durable, high-quality businesses provide steady cash payouts each quarter, all while leaving the door open for long-term price appreciation.

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »

Among dividend stocks in this category, a few stand out as strong opportunities right now: AbbVie (NYSE: ABBV), Chevron (NYSE: CVX), and PepsiCo (NASDAQ: PEP).

The word "Dividends" written on a blackboard in yellow chalk, surrounded by clip-art style images drawn in white chalk.

Image source: Getty Images.

AbbVie's comeback points to further dividend growth

Pharmaceutical company AbbVie has raised its dividend annually since being spun off from Abbott Laboratories in 2013. A few years ago, the company entered a rough patch due to the then-pending expiration of patent exclusivity for its Humira anti-inflammatory treatment.

However, thanks to the success of immunology therapies like Skyrizi and Rinvoq, AbbVie has experienced a rebound. Sales growth and operating income have bounced back. After making a further pivot toward immunology, through its pending acquisition of Apogee Therapeutics, AbbVie appears well-positioned for further earnings growth. Forecasts call for revenue and earnings growth of around 10% and 40%, respectively, during 2026.

As earnings growth continues, AbbVie remains well-positioned to continue its dividend growth streak. Currently, the stock has a forward dividend yield of around 2.75%, with annual dividend growth averaging nearly 6% over the past five years.

Chevron remains a Dividend King in the making

Integrated oil and gas company Chevron has nearly 40 years of consecutive dividend growth. That means it's just a little over a decade away from attaining Dividend King status. Dividend Kings are stocks with 50 or more years of consecutive dividend growth.

With a forward dividend yield of around 3.75%, Chevron has also raised its dividend by an average of 6% over the past five years. An additional wave of mid-single-digit dividend growth may be in the cards. Even as crude oil prices have eased since the geopolitically driven supply shocks earlier this year, they remain within a range that supports the energy company's long-term cash flow growth goals.

As announced last November, Chevron's game plan to "maintain capital and cost discipline" could lead to 10% annualized earnings growth between now and 2030 if Brent crude oil prices stay above $70 per barrel. Alongside cost-cutting measures, Chevron's game plan also entails leaning into growth opportunities, such as providing power solutions for artificial intelligence (AI) data centers.

PepsiCo: A contrarian buy among dividend stocks

PepsiCo shares have fallen out of favor in recent months. The packaged food and beverage company continues to struggle with declining U.S. market share, even as quarterly results beat forecasts.

Yet while the market remained bearish, much suggests ample rewards for those going contrarian at present price levels. Right now, the stock has a forward dividend yield of around 4.4%. PepsiCo is already a Dividend King, with a 54-year track record of annual dividend increases, and the company's dividend growth has averaged around 6% annually over the past five years.

As Morgan Stanley's Dara Mohsenian recently noted, factors like tariff refunds and continued strong international results could help offset recent concerns. Since PepsiCo's shares are trading for only 18 times forward earnings, while competitor Coca-Cola trades for 25 times forward earnings, there's ample upside potential if sentiment improves.

Should you buy stock in AbbVie right now?

Before you buy stock in AbbVie, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and AbbVie wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $369,577!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,301,557!*

Now, it’s worth noting Stock Advisor’s total average return is 908% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of July 23, 2026.

Thomas Niel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie and Chevron. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Gold Price Outlook For July 2026Gold trades near $4,140 on Tuesday, down 26% from January’s record high of $5,598 per ounce. This gold price prediction for July 2026 examines why the metal keeps falling and where it could bottom.Fiv
Author  Beincrypto
Jul 08, Wed
Gold trades near $4,140 on Tuesday, down 26% from January’s record high of $5,598 per ounce. This gold price prediction for July 2026 examines why the metal keeps falling and where it could bottom.Fiv
placeholder
Alphabet’s AI Chip Surprise Revives Bull Case for Beaten-Down Semiconductor StocksAlphabet (GOOGL) stock climbed about 3% on Monday. The trigger was a report from The Information that Google is building a new AI chip, called Frozen v2, to run its Gemini models up to 10 times more e
Author  Beincrypto
Jul 21, Tue
Alphabet (GOOGL) stock climbed about 3% on Monday. The trigger was a report from The Information that Google is building a new AI chip, called Frozen v2, to run its Gemini models up to 10 times more e
placeholder
AMD Stock Jumps 10% on Anthropic Deal: Can Nvidia’s Lead Hold?AMD stock jumped roughly 12% on Wednesday after Anthropic agreed to deploy up to 2 gigawatts of AMD’s Instinct MI450 GPUs. AMD will also invest up to $5 billion in the Claude maker.Anthropic is AMD’s
Author  Beincrypto
22 hours ago
AMD stock jumped roughly 12% on Wednesday after Anthropic agreed to deploy up to 2 gigawatts of AMD’s Instinct MI450 GPUs. AMD will also invest up to $5 billion in the Claude maker.Anthropic is AMD’s
placeholder
Tesla, Alphabet, IBM Report Today: Why Are Options Traders Paying 86% Volatility?Tesla, Alphabet, and IBM all report second-quarter earnings after Wednesday’s closing bell. Options traders are bracing for big single-day swings from all three.Recent history explains the nerves. Alp
Author  Beincrypto
22 hours ago
Tesla, Alphabet, and IBM all report second-quarter earnings after Wednesday’s closing bell. Options traders are bracing for big single-day swings from all three.Recent history explains the nerves. Alp
placeholder
IBM cuts year revenue forecast after stock plungesIBM dropped its full-year revenue growth target on Wednesday to between 4% and 5% from a prior forecast of over 5%, after sales of its mainframe hardware fell 42% in the second quarter. The cut confirms to shareholders who had watched the stock recover over the last few years that IBM’s most profitable legacy business...
Author  Cryptopolitan
22 hours ago
IBM dropped its full-year revenue growth target on Wednesday to between 4% and 5% from a prior forecast of over 5%, after sales of its mainframe hardware fell 42% in the second quarter. The cut confirms to shareholders who had watched the stock recover over the last few years that IBM’s most profitable legacy business...
goTop
quote